Quantigen Biosciences, a specialty contract research organization focused on medical diagnostics and device development through pharmaceutical and biotech industry partnerships, announced its plans to relocate and expand its headquarters from its existing location to a 40,000ft2 state-of-the-art facility located at the Round Room building in Fishers (10300 Kincaid Drive). Accompanying this announcement, the firm plans to add 30 new, high-wage jobs in the areas of quality & regulatory compliance and research by the end of 2023 and will invest $2.5 million into new lab and office space.
“The Fishers community has been home to Quantigen since our founding, so we are thrilled to have been able to find a facility that can support our expansion and allow us to continue operations in the city where we have been welcomed and supported. Mayor Fadness and his team have been incredibly supportive throughout our relocation search process. We are bullish for Quantigen’s future, as we are for the biotech prospects for our city and the region as a whole”
Quantigen, which was founded in Fishers in 2008, plans to double its workforce, a result of efforts in three strategic areas:
“Jami and his team at Quantigen are working on next-generation technology for the life science industry right here in Fishers,” said Fishers Mayor Scott Fadness. “Quantigen’s commitment to staying and investing in this community is exciting as we continue to see catalytic growth in this cluster that’s ripe for Fishers.”
The Indiana Economic Development Corporation offered Quantigen LLC up to $350,000 in conditional tax credits based on the company’s plans to create up to 23 new jobs by the end of 2023. These tax credits are performance-based, meaning the company is eligible to claim incentives once Hoosiers are hired.
“We’re thrilled to support Quantigen’s growing presence in Indiana as they continue strengthening our state’s life sciences sector, which contributes roughly $80 billion to Indiana’s economy,” said Interim Indiana Secretary of Commerce Jim Staton. “I’m confident Quantigen’s success will continue for years to come and grateful for the high-quality career opportunities they’re providing for Hoosiers.”
Fishers’ growing life science cluster is bolstered with this news and comes on the heels of recent life science firms announcing their growth and investment in the city, including: Stevanato, a foreign-direct investment equating to $145 million and 230 jobs; INCOG BioPharma, investing $60 million and 150 jobs; and Genezen, investing $7.8 million and 36 employees. The City of Fishers provided Quantigen with a $50,000 grant toward its buildout and moving expenses. The Redevelopment Commission approved the Economic Development Agreement at the February 2 meeting with the abatement approval being presented to City Council at the July meeting.
For more information about Quantigen or to learn about their job opportunities, visit quantigen.com.